Latest filing published 06 Aug 2026 for PFIZER INC, €72k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jennifer B. Damico (senior executive) discloses dealings in Pfizer Inc to SEC (Form 4). The record holds 23 filings, for trades running from 5 May 2021 to 5 August 2026.
On the market, this insider has only sold: 8 sales, €788k in total. The totals do not cover 1 filing with an undisclosed amount. Besides market trades, the filings include 7 share grants and 8 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
The newest entry dates from 6 August 2026: an open-market sale of €72k, in Pfizer Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations